Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

SCHERING-PLOUGH

(SGP)
SummaryNewsCompany 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news
Sector news Biopharmaceuticals
12/03Drugmakers cut prices by 62% on average to get China state insurance listing
RE
12/02Australia's CSL in exclusive talks for $7 billion buyout of Swiss Vifor Pharma - report
RE
12/02Vifor Says Regularly in Talks with Other Market Participants After Reports
CI
12/02CSL in Talks to Buy Vifor Pharma
CI
12/01Sage Therapeutics, Biogen Report Positive Data From Antidepressant Drug Candidate Zuran..
MT
12/01Viatris Wins Court Tussle Against Biogen as US Appeals Court Upholds Earlier Patent Rul..
MT
12/01Sage Therapeutics and Biogen Announce Positive, One-Year Zuranolone 50 mg Data in the O..
CI
11/30Biogen Loses Appeals Court Bid to Revive Multiple Sclerosis Drug Patent
MT
11/30US Court of Appeals Affirms District Court Decision That Biogen's 2028 Tecfidera Patent..
MT
11/30CANbridge Pharmaceuticals Secures WuXi Biologics Backing for $88 Million Hong Kong IPO
MT
11/29Australia shares rebound, gain 1% as investors absorb Omicron shock
RE
11/29Samsung Biologics, GreenLight Biosciences Enter Deal to Produce COVID-19 mRNA Vaccines
MT
11/29South Korean Stocks Fall for Fifth Session Over COVID-19 Variant Omicron Fears; Hyundai..
MT
11/24GreenLight Biosciences and Samsung Biologics Announce Collaboration to Build Capacity f..
CI
11/23Seqirus Announces U.S. FDA Approval for Multi-Dose Vial Presentation of First-Ever Adju..
CI
11/23South Korea’s Indexes Decline on Profit-Taking; Naver, LG Chem Decline over 2%
MT
11/22WuXi Biologics Announces Completion of GMP Production At 24,000L Line of Its Drug Subst..
CI
11/22Biogen's Alzheimer's Drug Reportedly Caused Brain Swelling in Over One-Third of Patient..
MT
11/22Study Shows Biogen's Alzheimer's Drug Reportedly Shows Brain Swelling in 35% of Patient..
MT
11/19RBC Cuts Price Target on Biogen to $277 From $295 Amid Alzheimer's Updates, Maintains S..
MT
11/19South Korean Stocks Break Three-Day Losses to Close Higher; Samsung Biologics Jumps 6% ..
MT
11/18Australia shares edge up on financials, healthcare boost
RE
11/18BMO Capital Initiates Coverage of Biogen With Outperform Rating, $315 Price Target
MT
11/18Asian Stock Markets Wobble on Tech, Property Outlooks
MT
11/18Nikkei 225 Off 0.3% Despite News on Government Stimulus Package
MT
11/18Novartis Said Considering Takeover in Biotech Sector
MT
11/18Nikkei dips but pares losses after report on larger stimulus
RE
11/17European Medicines Agency Committee Gives Negative Trend Vote on Biogen's Alzheimer's D..
MT
11/17Japanese shares dip as inflation worries hit global stocks
RE
11/17Health Care Stocks Flat To Lower Premarket Wednesday
MT
11/17Biogen, Eisai's Alzheimer's Drug Candidate Receives Negative Trend Vote by European Reg..
MT
11/17Biogen's Alzheimer's Drug Gets Negative Trend Vote in EU
DJ
11/17Biogen Inc. and Eisai Co., Ltd. Announces an Update on the Ongoing Review of the Market..
CI
11/16Biogen Secures European Marketing Approval for Multiple Sclerosis Treatment
MT
11/16Biogen Gets Europe OK for Vumerity Multiple Sclerosis Drug
DJ
11/16The European Commission Grants Marketing Authorization for VUMERITY? (diroximel fumarat..
CI
11/15Biogen's research chief Alfred Sandrock to retire
RE
11/15Biogen Inc. Announces Executive Changes
CI
11/15Samsung Biologics Co.,Ltd. Reports Earnings Results for the Third Quarter and Nine Mont..
CI
11/15Samsung's Lee visits U.S ahead of likely $17 billion chip plant decision-media
RE
11/15S.Korea stocks end 1% higher on chip, biopharma boost, U.S. data in focus
RE
11/15Australia shares end higher on strong Chinese data
RE
11/12REFILE-UPDATE 4-Biden will nominate industry-friendly Califf to lead U.S. FDA
RE
11/12Health Care Stocks Gain Premarket Friday
MT
11/11Biogen, Eisai Alzheimer Treatment Shows Positive Signs in Advanced Trial
DJ
11/11Biogen Says Clinical Trial Data Show Aduhelm Reduced Levels of Protein Linked With Alzh..
MT
11/11Biogen says Aduhelm lowers levels of second protein associated with Alzheimer's
RE
11/11Biogen Inc. and Eisai Co., Ltd. Announce New Phase 3 Data Show Positive Correlation Bet..
CI
11/11Biogen, Eisai Disclose Lecanemab Clinical Efficacy Results in Patients With Alzheimer's..
MT
11/11Eisai Co., Ltd. and Biogen Inc. Announces Presentation About Exploring Use of Plasma-Ba..
CI
1  2  3  4  5  6  7  8  9  10Next